Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTSKY : OTC)
 
 • Company Description   
Otsuka Holdings Co Ltd is a pharmaceutical company. It manufactures, sells, imports and exports pharmaceutical products, clinical testing and medical equipment for intractable diseases. Otsuka Holdings Co Ltd is based in Tokyo, Japan.

Number of Employees: 37,758

 
 • Price / Volume Information   
Yesterday's Closing Price: $36.53 Daily Weekly Monthly
20 Day Moving Average: 38,069 shares
Shares Outstanding: 1,074.19 (millions)
Market Capitalization: $39,239.98 (millions)
Beta:
52 Week High: $37.52
52 Week Low: $21.68
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 8.14% 2.86%
12 Week 9.86% 1.56%
Year To Date 28.94% 19.31%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2-16-4 Konan Minato-ku
-
TOKYO,M0 108-8241
JPN		 ph: 813-6717-1410
fax: -		 None http://www.otsuka.com/en
 
 • General Corporate Information   
Officers
Yoshiro Matsuo - Chief Executive Officer and President
Ichiro Otsuka - Chairman
Yuko Makino - Chief Financial Officer
Yoshiro Matsuo - Director
Shuichi Takagi - Director

Peer Information
Otsuka Holdings Co., Ltd. - Unsponsored ADR (GSAC)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (CASIF)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (ALCD.)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (OMNN)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (CGPI.)
Otsuka Holdings Co., Ltd. - Unsponsored ADR (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 689164101
SIC: 8880
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 07/30/26
Share - Related Items
Shares Outstanding: 1,074.19
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $39,239.98 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.71%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.26
Current Fiscal Year EPS Consensus Estimate: $1.86 Payout Ratio: 0.11
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 1.43% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/30/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 19.64
Trailing 12 Months: 15.41
PEG Ratio: 13.73
Price Ratios
Price/Book: 1.89
Price/Cash Flow: 12.23
Price / Sales: 2.35
EPS Growth
vs. Year Ago Period: 13.46%
vs. Previous Quarter: 47.50%
Sales Growth
vs. Year Ago Period: 5.09%
vs. Previous Quarter: -4.82%
ROE
03/31/26 - 12.33
12/31/25 - 12.52
09/30/25 - 16.11
ROA
03/31/26 - 9.11
12/31/25 - 9.21
09/30/25 - 11.87
Current Ratio
03/31/26 - -
12/31/25 - 2.17
09/30/25 - 2.16
Quick Ratio
03/31/26 - -
12/31/25 - 1.67
09/30/25 - 1.65
Operating Margin
03/31/26 - 15.01
12/31/25 - 14.76
09/30/25 - 18.53
Net Margin
03/31/26 - 15.01
12/31/25 - 14.76
09/30/25 - 18.53
Pre-Tax Margin
03/31/26 - -
12/31/25 - 18.96
09/30/25 - -
Book Value
03/31/26 - -
12/31/25 - 19.33
09/30/25 - 18.52
Inventory Turnover
03/31/26 - -
12/31/25 - 2.01
09/30/25 - -
Debt-to-Equity
03/31/26 - -
12/31/25 - 0.05
09/30/25 - 0.05
Debt-to-Capital
03/31/26 - -
12/31/25 - 5.11
09/30/25 - 5.20
 

Powered by Zacks Investment Research ©